Antimetabolites: all 7,479 studies that test it
Page 66 of 75. Open to participants first (1,134), then studies with results posted, then the rest; newest registration first within each.
- Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid CarcinomaTerminatedNCT00216424Phase 4
- Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung CancerTerminatedNCT00216216Phase 2
- Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaTerminatedNCT00216164Phase 2
- Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & NeckTerminatedNCT00216138Phase 2
- Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast CancerTerminatedNCT00216073Phase 2
- Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast CancerCompletedNCT00216021Phase 2
- Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal CancerCompletedNCT00215982Phase 2
- Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00215514Early Phase 1
- Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor MalignanciesCompletedNCT00215501Phase 1
- Vinblastine and Methotrexate in Children With Pulmonary Vein StenosisCompletedNCT00215046Phase 2
- A Study of Weekly Taxotere and Xeloda in Metastatic Breast CancerCompletedNCT00214864Phase 2
- Vascular Pathophysiology in Obstructive Sleep ApneaWithdrawnNCT00214084Not applicable
- XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00212615Phase 2/3
- Patients Preference for Oral or i.v. TherapyCompletedNCT00212589Phase 3
- Serum Proteomics to Predict Gemcitabine Sensitivity in Breast CancerCompletedNCT00212069Phase 2
- Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell CarcinomaCompletedNCT00212043Phase 2
- Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's LymphomaCompletedNCT00210379Phase 2
- Phase II Trial of Combined Modality Treatment in Primary Central Nervous System LymphomaCompletedNCT00210314Phase 2
- Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid CarcinomaCompletedNCT00210041Phase 2
- Methotrexate and Cyclosporine in Treatment of Early Rheumatoid ArthritisCompletedNCT00209859Phase 4
- Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.CompletedNCT00209716Phase 1/2
- Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal CancerTerminatedNCT00209703Phase 2
- Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.CompletedNCT00209690Phase 1/2
- Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic CancerSuspendedNCT00209677Phase 1/2
- Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCLStatus unknownNCT00209222Phase 3
- Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of EsophagusTerminatedNCT00208936Phase 2
- Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic MalignanciesCompletedNCT00208923Phase 2
- Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced MalignanciesCompletedNCT00207129Phase 1
- Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)CompletedNCT00206219Phase 3
- XELOX for Metastatic Breast CancerCompletedNCT00204776Phase 2
- A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and NeckCompletedNCT00203905Phase 2
- Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric CancerCompletedNCT00202969Phase 3
- Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00202800Phase 2
- A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00201669Phase 2
- A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal CarcinomaCompletedNCT00201396Phase 3
- A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma PatientsTerminatedNCT00201344Phase 3
- Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon CancerStatus unknownNCT00201331Phase 2
- Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary TractCompletedNCT00201305Phase 2
- Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With DepocytCompletedNCT00199108Phase 2/3
- Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in AdultsCompletedNCT00199082Phase 4
- Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade LymphomaCompletedNCT00199043Phase 3
- German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)CompletedNCT00198991Phase 4
- German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00198978Phase 4
- Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IVCompletedNCT00198393Phase 2
- Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast CancerCompletedNCT00198237Phase 2
- Safety and Effectiveness of D-Cycloserine in Children With AutismCompletedNCT00198120Phase 3
- Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ CancerStatus unknownNCT00197431Phase 2
- A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)CompletedNCT00196872Phase 3
- Study in Elderly Patients With Early Breast Cancer (ICE)CompletedNCT00196859Phase 3
- Mono Efficacy of Capecitabine (MoniCa)CompletedNCT00196820Phase 2
- Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AMLCompletedNCT00195104Phase 1/2
- Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDSCompletedNCT00195000Phase 2
- Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast CancerCompletedNCT00194727Phase 2
- Two-Dose Methotrexate for Ectopic PregnancyCompletedNCT00194272Phase 3
- Idarubicin Based Combined Modality Therapy in Primary CNS LymphomaCompletedNCT00193973Phase 2
- Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.CompletedNCT00193882Phase 3
- Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00193466Phase 2
- Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung CancerCompletedNCT00193362Phase 3
- Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly PatientsCompletedNCT00193323Phase 2
- Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal CancerCompletedNCT00193141Phase 2
- Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast CancerTerminatedNCT00193102Phase 2
- Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast CancerCompletedNCT00193076Phase 2
- Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast CancerCompletedNCT00193011Phase 3
- Concurrent Xeloda and Radiotherapy for Bone MetastasesStatus unknownNCT00192777Phase 2
- Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic CancerCompletedNCT00192712Phase 2/3
- Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or TaxanesCompletedNCT00192101Phase 2
- A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric CarcinomaCompletedNCT00192088Phase 2
- A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast CancerCompletedNCT00192062Phase 2
- A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder CancerCompletedNCT00192049Phase 2
- 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP RegimenCompletedNCT00191971Phase 2
- Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC ChemotherapyCompletedNCT00191841Phase 2
- Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung CancerCompletedNCT00191763Phase 2
- A Study of Pemetrexed in Small Cell Lung Cancer, Which Has ReturnedCompletedNCT00191750Phase 2
- Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.CompletedNCT00191711Phase 2
- A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerCompletedNCT00191672Phase 2
- Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.CompletedNCT00191620Phase 2
- Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic CancerCompletedNCT00191568Phase 2
- Gemcitabine and Pemetrexed in Primary Unknown AdenocarcinomaCompletedNCT00191503Phase 2
- A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung CancerCompletedNCT00191490Phase 2
- Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic AgentsCompletedNCT00191438Phase 3
- A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the LiverCompletedNCT00191412Phase 2
- A Trial for HER2 Positive Breast Cancer Patients With Metastatic DiseaseCompletedNCT00191373Phase 2
- A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast CancerCompletedNCT00191347Phase 2
- Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung CancerCompletedNCT00191256Phase 2
- Docetaxel vs. Docetaxel-Gemcitabine in Breast CancerCompletedNCT00191243Phase 2
- Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung CancerCompletedNCT00191230Phase 2
- Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLCCompletedNCT00191126Phase 3
- A Trial for Patients With Gestational Trophoblastic DiseaseCompletedNCT00190918Phase 2
- A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00190840Phase 2
- Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric CarcinomaCompletedNCT00190801Phase 2
- A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of MesotheliomaCompletedNCT00190762Phase 3
- A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung CancerCompletedNCT00190710Phase 3
- A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic UrticariaTerminatedNCT00189878Phase 2
- Antenatal Allopurinol During Fetal HypoxiaStatus unknownNCT00189007Phase 3
- Study of Adjuvant Radiochemotherapy for Gastric CancerCompletedNCT00188266Phase 1/2
- Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)CompletedNCT00188136Phase 2
- Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHLCompletedNCT00187161Phase 2
- Treatment for Patients With Stage III or IV Non-Hodgkin LymphomaCompletedNCT00187122Not applicable
- A Study of Children With Refractory or Relapsed ALLCompletedNCT00187083Phase 3
- Large Cell Lymphoma Pilot Study IIICompletedNCT00187070Not applicable